Showing results (61-70 of 339) with videos related to

Sort By:
Pageof 34
Blood|March 9, 2013
RUNX1/AML1 mutant collaborates with BMI1 overexpression in the development of human and murine myelodysplastic syndromesYuka Harada, Daichi Inoue, Ye Ding, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 12, 2026
Changes in Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for FLT3-ITD-mutated Acute Myeloid Leukemia in the FLT3 Inhibitor EraAtsushi Jinguji, Shuhei Kurosawa, Takashi Toya, et al.
Leukemia|January 7, 2026
Advances in the treatment and prognosis of aggressive NK-cell leukemia: results from the ANKL22 studyAyumi Fujimoto, Takeshi Maeda, Noriko Doki, et al.
International Journal of Molecular Sciences|January 11, 2019
Recipient <i>ADAMTS13</i> Single-Nucleotide Polymorphism Predicts Relapse after Unrelated Bone Marrow Transplantation for Hematologic MalignancyHaruka Nomoto, Akiyoshi Takami, J Luis Espinoza, et al.
Transplantation and Cellular Therapy|March 17, 2022
The Clinical Significance of BCR-ABL1 Mutations in Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Cell TransplantationTakayoshi Tachibana, Takeshi Kondo, Naoyuki Uchida, et al.
International Journal of Hematology|June 18, 2024
Asciminib in Patients With CML-CP Previously Treated With ≥ 2 Tyrosine Kinase Inhibitors: 96-Week Results From the Japanese Subgroup Analysis of the ASCEMBL StudyYosuke Minami, Noriko Doki, Hiroshi Matsuoka, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2026
Outcomes of two or more rounds of hematopoietic stem cell transplantation using total body irradiation for hematological malignanciesKeiko Nemoto Murofushi, Yuho Najima, Satoshi Kito, et al.
International Journal of Hematology|July 30, 2022
Immunological influence of serum-free manufactured umbilical cord-derived mesenchymal stromal cells for steroid-resistant acute graft-versus-host diseaseTokiko Nagamura-Inoue, Seiko Kato, Yuho Najima, et al.
Cancer Medicine|September 28, 2022
Asciminib vs bosutinib in CML patients pretreated with ≥2 tyrosine kinase inhibitors: Results from the Japanese subgroup analysis of ASCEMBL studyJunichiro Yuda, Noriko Doki, Hiroshi Matsuoka, et al.
Hematology/Oncology and Stem Cell Therapy|September 25, 2016
Central nervous system infection following allogeneic hematopoietic stem cell transplantationRyo Hanajiri, Takeshi Kobayashi, Kosuke Yoshioka, et al.
Pageof 34